Claims for Patent: 5,545,727

Summary for Patent: 5,545,727

Title:	DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
Abstract:	The alpha subunits of hemoglobin, which in nature are formed as separate polypeptide chains which bind noncovalently to the beta subunits, are here provided in the form of the novel molecule di-alpha globin, a single polypeptide chain defined by connecting the two alpha subunits either directly via peptide bond or indirectly by a flexible amino acid or peptide linker. Di-alpha globin may be combined in vivo or in vitro with beta globin and heme to form hemoglobin. Di-alpha globin is expressed by recombinant DNA techniques. Di-beta globin may be similarly obtained. DNA encoding alpha globin fusion proteins is provided.
Inventor(s):	Hoffman; Stephen J. (Denver), Looker; Douglas L. (Lafayette, CO), Nagai; Kiyoshi (Cambridge, GB2)
Assignee:	Somatogen, Inc. (Boulder, CO)
Application Number:	07/789,179
Patent Claims:	1. A DNA molecule comprising a DNA sequence coding on expression for non-naturally occurring, genetically fused, pseudodimeric di-alpha globin-like polypeptide consisting essentially of two and only two alpha globin-like domains, connected either directly by one peptide bond or by a peptide linker of 1-5 amino acids into a single unbranched polypeptide chain, said chain being capable of associating with beta globin and incorporating heme to form a pseudotetrameric hemoglobin-like protein with reversible oxygen binding activity. 2. The DNA molecule claim 1 wherein the amino acids of the linker are selected from the group consisting of alanine, threonine, lysine, aspartic acid, arginine, serine, asparagine, proline and glycine. 3. The DNA molecule claim 2 wherein the linker consists of one or more glycines. 4. The DNA molecule claim 1 wherein each globin-like domain has at least about 75% sequence identity with human alpha globin. 5. The DNA molecule claim 1 wherein each globin-like domain is essentially identical in sequence with human alpha globin. 6. The DNA molecule of claim 1 wherein said globin-like domains are essentially identical, but wherein at a predetermined position, a first globin-like domain has a cysteine residue and a second globin-like domain has a residue other than cysteine. 7. A DNA molecule encoding a human hemoglobin-like protein, said DNA molecule comprising a first gene encoding a di-alpha globin-like polypeptide and a second gene encoding a beta-globin-like polypeptide; said polypeptides being assemblable with heme to form a human hemoglobin-like protein, having reversible oxygen binding activity, said di-alpha globin-like polypeptide consisting essentially of two and only two alpha globin-like domains, connected either directly by one peptide bond or by a peptide linker of 1-5 amino acids into a single, unbranched polypeptide chain. 8. The DNA molecule of claim 7, said protein being a pseudotetramer. 9. The DNA molecule of claim 7, wherein the alpha globin-like domains of said di-alpha-globin-like polypeptide each have at least 75% sequence identity with human alpha globin, and the beta globin-like polypeptides each have at least 75% sequence identity with human beta globin. 10. The DNA molecule of claim 7, wherein the alpha globin-like domains are essentially identical in sequence with human alpha globin and the beta globin-like polypeptides are essentially identical in sequence with human beta globin. 11. The DNA molecule of claim 10 which comprises a sequence which encode a low affinity hemoglobin mutant. 12. The DNA molecule of claim 10 which comprises a sequence which encode a high affinity hemoglobin mutant. 13. The DNA molecule of claim 10 wherein the beta globin-like polypeptide comprises a Presbyterian mutation. 14. A recombinant DNA molecule according to claim 1 comprising expressible first and second DNA sequences encoding first and second alpha globin-like polypeptide sequences and optionally a linker DNA sequence encoding a linker amino acid sequence, said first and second polypeptide sequences and if included said linker amino acid sequence being expressed as a single polypeptide chain, said chain being capable of associating with beta globin and incorporating heme to form a human hemoglobin-like protein with reversible oxygen-binding activity. 15. The recombinant DNA molecule of claim 14, further comprising a third DNA sequence encoding a beta globin-like polypeptide. 16. The molecule of claim 15, wherein said first DNA sequence, linker DNA sequence, and second DNA sequence define a single cistron of a polycistronic operon and said third DNA sequence defines another cistron thereof, said cistrons being transcribed from a common promoter. 17. The molecule of claim 16 wherein the common promoter is the Tac promoter. 18. A method of producing a human hemoglobin-like protein with reversible oxygen binding activity wherein the two alpha subunits of native hemoglobin are replaced by a single di-alpha globin-like polypeptide, which comprises providing a host transformed with a recombinant DNA molecule according to claim 14, cultivating said host under conditions whereunder it expresses said di-alpha globin-like polypeptide, and combining said polypeptide with beta globin and heme to obtain a human hemoglobin like protein. 19. The method of claim 18 wherein the di-alpha globin-like polypeptide and the beta-globin are co-expressed from said recombinant DNA molecule and heme is provided by said host and incorporated to form said hemoglobin-like protein. 20. The method of claim 18 wherein the host is a yeast cell. 21. The method of claim 18 wherein the host is a bacterial cell. 22. The DNA molecule of claim 1 where the carboxy terminal residue of one domain is directly connected to the amino terminal residue of another domain. 23. The DNA molecule of claim 3 wherein the linker consists of 1-3 glycines. 24. The DNA molecule of claim 2 wherein the amino acids of the linker are selected from the group consisting of glycine and proline. 25. The DNA molecule of claim 1 wherein the linker comprises two or more glycines. 26. The DNA molecule of claim 13 wherein the domains are connected directly or by a linker consisting of 1-3 glycines. 27. The DNA molecule of claim 1 wherein the sequence encoding the polypeptide is intron-free. 28. The DNA molecule of claim 1 wherein each globin-like domain is essentially identical in sequence with a vertebrate alpha globin. 29. The DNA molecule of claim 1 wherein each globin-like domain is essentially identical in sequence with a mammalian alpha globin. 30. The DNA molecule of claim 1 wherein each globin-like domain comprises, at corresponding positions, the amino acid residues which are invariant among vertebrate alpha globins. 31. The DNA molecule of claim 1 wherein each globin-like domain comprises, at corresponding positions, the amino acid residues which are invariant among mammalian alpha globins. 32. The DNA molecule of claim 1 wherein each globin-like domain differs from at least one vertebrate globin solely by mutations corresponding to an allelic variation in human globin and/or substitutions wherein each substituted amino acid is replaced by another in the same exchange group, the exchange groups being: I Ala, Ser, Thr, Pro, Gly II Asn, Asp, Glu, Gln III His, Arg, Lys IV Met, Leu, Ile, Val, Cys V Phe, Tyr, Trp 33. The DNA molecule of claim 1 wherein each globin-like domain differs from at least one mammalian globin solely by mutations corresponding to an allelic variation in human globin and/or substitutions wherein each substituted amino acid is replaced by another in the same exchange group, the exchange groups being: I Ala, Ser, Thr, Pro, Gly II Asn, Asp, Glu, Gln III His, Arg, Lys IV Met, Leu, Ile, Val, Cys V Phe, Tyr, Trp 34. The DNA molecule of claim 1 wherein each globin-like domain differs from at least one human globin solely by mutations corresponding to an allelic variation in human globin and/or substitutions wherein each substituted amino acid is replaced by another in the same exchange group, the exchange groups being: I Ala, Ser, Thr, Pro, Gly II Asn, Asp, Glu, Gln III His, Arg, Lys IV Met. Leu, Ile, Val, Cys V Phe, Tyr, Trp 35. The DNA molecule of claim 1 wherein each globin-like domain has at least 75% sequence identity with a mammalian alpha globin. 36. The DNA molecule of claim 1 wherein each globin-like domain has at least the same degree of sequence identity with human alpha globin as does the corresponding carp globin. 37. The DNA molecule of claim 1 wherein the linker comprises two or more glycines, and at least the first and last amino acids of the linker are glycines. 38. The DNA molecule of claim 37 wherein the amino acids of the linker are selected from the group consisting of alanine, threonine, lysine, aspartic acid, arginine, serine, asparagine, proline and glycine. 39. The DNA molecule of claim 1 where each globin-like domain has at least the same degree of sequence identity with human alpha or beta globin as does the corresponding rhesus monkey globin. 40. The DNA molecule of claim 1 where each globin-like domain has at least the same degree of sequence identity with human alpha or beta globin as does the corresponding bovine globin.

Details for Patent 5,545,727

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2013-08-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2013-08-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2013-08-13